Deutsche Bank Ag\ Xenetic Biosciences, Inc. Transaction History

Deutsche Bank Ag\

  • $218 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020
SELL
$0.49 - $1.69 $12,466 - $42,995
-25,441 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$1.05 - $1.66 $26,713 - $42,232
25,441 New
25,441 $36,000

About Xenetic Biosciences, Inc.

XBIO Quotes by TradingView
  • Ticker XBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,166,600
  • Market Cap $64.6M
  • Description
  • Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the discovery, research, and development of biologic drugs and oncology therapeutics. It advances cell-base...
More about XBIO
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email